-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Acute lymphoblastic leukemia (ALL) is the main type of acute leukemia in adults and is a group of diseases
Currently, in patients with acute lymphoblastic leukemia who received allo-HSCT, there is still controversy
On September 9, 2022, Liu Qi's team from Southern Hospital of Southern Medical University published online in the journal Journal of Clinical Oncology (IF=51) entitled "Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B.
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a treatment for patients with acute lymphoblastic leukemia (ALL
Overall, the findings suggest that the bucy regimen was not inferior in overall survival, recurrence, disease-free survival, and non-relapse mortality in patients with STANDARD risk B-ALL of CR1 who received allogeneic genes matched with HLA compared with TBI-Cy
—END—
The content is [iNature]